The latest results from the trials of Israel’s homegrown COVID-19 vaccine indicate the shot may provide longer-term protection than the inoculation developed by Pfizer-BioNTech, which is the shot given to most Israelis.

Channel 12 news reported that 230 volunteers who received the highest dosage of the vaccine, developed by the Israel Institute for Biological Research in Ness Ziona, were notified that they did not need a third dose of the vaccine as their protection remained high, six months after getting a second dose.

The report did not detail how protection was measured, though presumably this was based on antibody counts.

Meanwhile, participants who received low or medium doses have been told to get vaccinated with Pfizer or Moderna shots, as those dosages do not appear to offer significant protection.... Read More: Times of Israel